Orthofix International (OFIX) Misses Q1 EPS by 19c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500 volatile in choppy trading; Mideast deal, SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Orthofix Reports First Quarter 2022 Results
May 6, 2022 7:00 AM EDTNet sales of $106.4 million, an increase of 1% on a reported basis and 2% on a constant currency basis over prior year New product sales drive solid growth in Biologics, Spinal Implants, and Orthopedics FDA grants PMA for AccelStim bone growth stimulator LIPUS technology expands our indications into fresh fracture care FDA clearance received for the TrueLok EVO Ring Fixation system, which enables clear radiographic visualization Reaffirming 2022 guidance
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ: OFIX) today reported... More
